Case details

Eli Lilly and Company (Appellant) v Actavis UK Limited and others (Respondents)

Case ID: UKSC 2015/0197

Case summary

Issue(s)

Whether a new pemetrexed based cancer treatment produced by Actavis UK Limited and others infringes Eli Lilly and Company’s patent and its foreign designations either indirectly under s.60(2) of the Patents Act 1977 (matter for appeal) or directly under a proper interpretation of Article 69 of the Europe Patent Convention 2000 (matter for cross-appeal).

Facts

In order to market a new cancer treatment product, Actavis UK Limited and others applied for declarations of non-infringements of a European patent owned by Eli Lilly and Company and registered in the UK and the corresponding national designations in France, Italy and Spain.

Judgments appealed

Parties

Appellant

Eli Lilly and Company

Respondents

Actavis UK Limited and others

Appeal

Justices

Lord Neuberger, Lord Mance, Lord Clarke, Lord Sumption, Lord Hodge

Hearing start date

04 Apr 2017

Hearing finish date

06 Apr 2017

Watch hearing
04 Apr 2017 Morning session Afternoon session
05 Apr 2017 Morning session Afternoon session
06 Apr 2017 Morning session Afternoon session